Coronary vascular occlusion mediated via thromboxane A2-prostaglandin endoperoxide receptor activation in vivo.

The use of enzyme inhibitors to clarify the role of thromboxane A2 in vasoocclusive disease has been complicated by their non-specific action. To address this problem we have examined the effects of thromboxane A2/prostaglandin endoperoxide receptor antagonism in a canine model of platelet-dependent...

Description complète

Détails bibliographiques

Publié dans:	J Clin Invest
Auteurs principaux:	Fitzgerald, D J, Doran, J, Jackson, E, FitzGerald, G A
Format:	Artigo
Langue:	Inglês
Publié:	American Society for Clinical Investigation 1986
Sujets:	Research Article
Accès en ligne:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC423371/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3003161/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI112329
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!